Medicare Enrolled
Dr. Andrew Panakos, M.D.
Cardiovascular Disease · Boca Raton, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Panakos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Panakos? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Panakos
Dr. Andrew Panakos is a cardiovascular disease in Boca Raton, FL, with 12 years in practice. Based on federal Medicare data, Dr. Panakos performed 6,609 Medicare services across 4,337 unique beneficiaries.
Between the years covered by Open Payments, Dr. Panakos received a total of $18,342 from 54 pharmaceutical and/or device companies across 553 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Panakos is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice▲ Top 14% volume in FL$ $18,342 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,609
Medicare services
Top 14% in FL for cardiovascular disease
4,337
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~551 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,161 | $93 | $132 |
| Electrocardiogram (EKG), 12-lead | 823 | $11 | $16 |
| Hospital follow-up visit, moderate complexity | 739 | $63 | $83 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 390 | $86 | $119 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 353 | $28 | $38 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 329 | $20 | $30 |
| Regadenoson injection (Lexiscan) for heart stress test | 328 | $40 | $94 |
| Echocardiogram, transthoracic | 327 | $148 | $203 |
| EKG interpretation and report | 318 | $7 | $9 |
| New patient office visit (45-59 min) | 285 | $122 | $177 |
| Initial hospital admission, moderate complexity | 263 | $103 | $137 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 198 | $338 | $450 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 197 | $48 | $74 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 113 | $10 | $52 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 82 | $17 | $24 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 77 | $9 | $13 |
| Cardiac catheterization | 73 | $193 | $320 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 68 | $18 | $24 |
| Remote pacemaker/defibrillator monitoring, 90 days | 59 | $17 | $25 |
| Insertion of heart rhythm monitor under skin | 44 | $3,377 | $4,413 |
| Remote pacemaker monitoring, 90 days | 44 | $22 | $31 |
| Ultrasonic guidance for blood vessel access | 42 | $12 | $16 |
| Interpretation and report of ultrasound of heart | 36 | $66 | $95 |
| Coronary stent placement | 34 | $453 | $648 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 32 | $60 | $78 |
| Ultrasound of heart, follow-up | 24 | $17 | $25 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 22 | $79 | $106 |
| Heart rhythm recording of continous external ekg over 8-15 days | 21 | $9 | $12 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 20 | $17 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 19 | $15 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 19 | $10 | $14 |
| External shock to heart to regulate heart beat | 15 | $81 | $161 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $277 | $404 |
| Ultrasound of both sides of head and neck blood flow | 15 | $114 | $157 |
| Removal of heart rhythm monitor from under the skin | 12 | $69 | $142 |
| Office visit, established patient, complex (40-54 min) | 12 | $130 | $184 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.1% high complexity
13.5% medium
78.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,342
Total received (2018-2024)
Avg $2,620/year across 7 years
Top 15% in FL for cardiovascular disease
54
Companies
553
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,932 (92.3%)
Scientific / Research
Research funding and grants
$1,105 (6.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$305 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,363
2023$3,790
2022$2,303
2021$2,852
2020$1,913
2019$1,344
2018$1,777
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$3,792
Penumbra, Inc.
$1,701
Medtronic Vascular, Inc.
$1,672
Boston Scientific Corporation
$1,196
AstraZeneca Pharmaceuticals LP
$1,059
Novartis Pharmaceuticals Corporation
$845
PFIZER INC.
$756
Amgen Inc.
$740
Janssen Pharmaceuticals, Inc
$465
Boehringer Ingelheim Pharmaceuticals, Inc.
$458
SANOFI-AVENTIS U.S. LLC
$437
E.R. Squibb & Sons, L.L.C.
$432
ASAHI INTECC USA, INC.
$401
ShockWave Medical, Inc
$375
Merck Sharp & Dohme LLC
$343
Astellas Pharma US Inc
$305
ABIOMED
$252
Regeneron Healthcare Solutions, Inc.
$203
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$201
Amarin Pharma Inc.
$193
Esperion Therapeutics, Inc.
$182
ZOLL Circulation Inc
$180
Impulse Dynamics (USA) Inc.
$175
Chiesi USA, Inc.
$173
Cardiovascular Systems Inc.
$160
HEARTFLOW, INC.
$141
Inari Medical, Inc.
$126
Medtronic, Inc.
$120
Merck Sharp & Dohme Corporation
$115
Edwards Lifesciences Corporation
$109
Bayer HealthCare Pharmaceuticals Inc.
$85
Philips Electronics North America Corporation
$84
Shockwave Medical, Inc
$80
Kestra Medical Technology Services, Inc.
$76
CVRx, Inc.
$74
HeartFlow, Inc.
$72
Kiniksa Pharmaceuticals International, plc
$54
Lexicon Pharmaceuticals, Inc.
$49
iRhythm Technologies, Inc.
$49
Kowa Pharmaceuticals America, Inc.
$48
AGEPHA Pharma FZ LLC
$43
Alnylam Pharmaceuticals Inc.
$41
Kiniksa Pharmaceuticals, Ltd.
$41
Philips North America LLC
$32
Novo Nordisk Inc
$32
Terumo Medical Corporation
$29
Bayer Healthcare Pharmaceuticals Inc.
$25
Lundbeck LLC
$22
ATRICURE, INC.
$22
Amryt Pharma Holdings Ltd
$21
ARBOR PHARMACEUTICALS, INC.
$15
GENZYME CORPORATION
$14
BOSTON SCIENTIFIC CORPORATION
$14
CARDIVA MEDICAL, INC.
$14
Top 3 companies account for 39.1% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (5091) Amb Mon & Diag Und · AMPLATZER AMULET · AMPLATZER Occluders · ASAHI PTCA Guide Wire · ATRICLIP LAA EXCLUSION SYSTEM · AVEIR · Allure Quadra RF CRT Pacemaker · Arcalyst · Assure WCD · BRILINTA · Barostim Neo System · CAMZYOS · CONFIRM RX · CRT-Ds · Cardiva VASCADE MVP VVCS 6-12F · Confirm Rx · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DRAGONFLY OPSTAR · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · Edwards SAPIEN XT Transcatheter Heart Valve · Evera · FABRAZYME · FARXIGA · FFRct · FLOWTRIEVER CATHETER · GALLANT · GENERAL - STRUCTURAL · General - Therapies · Glidesheath · HeartWare HVAD · Impella · Indigo System · Inpefa · Integrity · JARDIANCE · JOT DX · JUXTAPID · KENGREAL · Kerendia · LEQVIO · LINQ II · LIVALO · LODOCO · LifeVest · Livalo · MULTAQ · MitraClip System · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · OPTIMIZER · Optisure Defibrillation ICD Lead · Ozempic · PERIPHERAL VASCULAR · PRALUENT · PRESSUREWIRE · Perclose ProGlide suture mediated closure system · PressureWire FFR · QUADRA ALLURE MP · REVEAL LINQ · Repatha · Resolute · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Temperature Management System · Trifecta GT Tissue Heart Valve · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · Vascular Lithotripsy · Verquvo · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · XIENCE SIERRA · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $278 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
259
Per 100K population
17.2
County median income
$81,115
Nearest hospital
BOCA RATON REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Panakos is a clinical cardiology specialist, with above-average Medicare volume (top 14% in FL), and high industry engagement (low-engagement, top 15%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Panakos experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Panakos performed 1,161 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Panakos receive payments from pharmaceutical companies?
Yes. Dr. Panakos received a total of $18,342 from 54 companies across 553 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Panakos's costs compare to other cardiovascular diseases in Boca Raton?
Dr. Panakos's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Panakos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Boca Raton
Browse cardiovascular diseases in Boca Raton ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Penumbra, Inc. Payments to Doctors
See all physicians who received payments from Penumbra, Inc..
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology